Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD

Scandinavian Journal of Gastroenterology

Volumn 49, Issue 9, 2014, Pages 1111-1118

  Önnerhag, Kristina ^a   Nilsson, Peter M ^b   Lindgren, Stefan ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Hepatocellular carcinoma; Liver cirrhosis; Metabolic syndrome; Mortality; Non alcoholic fatty liver disease

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HISTORY; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; RISK; SURVIVAL RATE; SWEDEN; AGED; BIOPSY; CARCINOMA, HEPATOCELLULAR; COMPLICATION; DISEASE COURSE; EPIDEMIOLOGY; LIVER; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; BIOPSY; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; SURVIVAL RATE; SWEDEN;

EID: 84906323512     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2014.934911     Document Type: Article

References (33)

1. Armstrong MJ, Houlihan DD, Bentham L, Shaw JC, Cramb R, Olliff S, et al. Presence and severity of nonalcoholic fatty liver disease in a large prospective primary care cohort. J Hepatol 2012;56:234-40
2. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-Alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55: 2005-23
3. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010;53:372-84
4. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-31
5. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study. Hepatology 2005;42:44-52
6. Torres DM,Williams CD, Harrison SA. Features, diagnosis, and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2012;10:837-58
7. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917-23
8. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2012;51:1972-8
9. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology 2005;129:113-21
10. Dam-Larsen S, FranzmannM,Andersen IB, Christoffersen P, Jensen LB, Sorensen TI, et al. Long term prognosis of fatty liver: Risk of chronic liver disease and death. Gut 2004; 53:750-5
11. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-Term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865-73
12. Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T, et al. Long-Term follow-up of patients with nonalcoholic fatty liver. Clin GastroenterolHepatol 2009;7:234-8
13. Soderberg C, Stal P, Askling J, Glaumann H, Lindberg G, Marmur J, et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010;51:595-602
14. Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: A longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005;42:132-8
15. Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-Analysis. Hepatology 2011;54:1082-90
16. Berglund G, Nilsson P, Eriksson K.F, Nilsson JA, Hedblad B, Kristenson H, et al. Long-Term outcome of the Malmo preventive project: Mortality and cardiovascular morbidity. J Intern Med 2000;247:19-29
17. Kristenson H, Trell E. Indicators of alcohol consumption: Comparisons between a questionnaire (Mm-MAST), interviews and serum gamma-glutamyl transferase (GGT) in a health survey of middle-Aged males. Br J Addict 1982;77: 297-304
18. af Sillen U, Nilsson JA, Mansson NO, Nilsson PM. Selfrated health in relation to age and gender: Influence on mortality risk in the Malmo Preventive Project. Scand J Public Health 2005;33:183-9
19. Verbaan H, Widell A, Lindgren S, Lindmark B, Nordenfelt E, Eriksson S. Hepatitis C in chronic liver disease: An epidemiological study based on 566 consecutive patients undergoing liver biopsy during a 10-year period. J Intern Med 1992;232:33-42
20. White DL, Kanwal F, El-Serag HB. Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review. Clin Gastroenterol Hepatol 2012;10:1342-59.e2
21. Torres DM, Harrison SA. Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: Fertile soil. Semin Liver Dis 2012;32:30-8
22. Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-Alcoholic fatty liver disease: An emerging menace. J Hepatol 2012;56:1384-91
23. Ertle J, Dechene A, Sowa J.P, Penndorf V, Herzer K, Kaiser G, et al. Non-Alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int J Cancer 2011;128:2436-43
24. Alexander J, Torbenson M, Wu TT, Yeh MM. Nonalcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: A clinical and pathological study. J Gastroenterol Hepatol 2013;28:848-54
25. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011;364: 829-41
26. Önnerhag K, Nilsson PM, Lindgren S. Insulin resistance with impaired fasting glucose increases the risk of NAFLD. OJGas 2013;3:170-6
27. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.NEngl JMed 2010;363:1341-50
28. Ludwig J, Viggiano TR, McGill DB, Oh B.J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-8
29. Hansen AB, Hvidtfeldt UA, Gronbaek M, Becker U, Nielsen AS, Tolstrup JS. The number of persons with alcohol problems in the Danish population. Scand J Public Health 2011;39:128-36
30. Romelsjo A, Allebeck P, Andreasson S, Leifman A. Alcohol, mortality and cardiovascular events in a 35 year follow-up of a nationwide representative cohort of 50,000 Swedish conscripts up to age 55. Alcohol Alcohol 2012;47:322-7
31. Ekstedt M, Franzen LE, Holmqvist M, Bendtsen P, Mathiesen UL, Bodemar G, et al. Alcohol consumption is associated with progression of hepatic fibrosis in nonalcoholic fatty liver disease. Scand J Gastroenterol 2009; 44:366-74
32. Dunn W, Xu R, Schwimmer JB. Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology 2008;47:1947-54
33. Dunn W, Sanyal AJ, Brunt EM, Unalp-Arida A, Donohue M, McCullough AJ, et al. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-Alcoholic fatty liver disease (NAFLD). J Hepatol 2012;57:384-91.